1,843 Shares in Chemed Co. (NYSE:CHE) Acquired by W.E. Donoghue & Co. LLC

W.E. Donoghue & Co. LLC bought a new position in Chemed Co. (NYSE:CHE) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,843 shares of the company’s stock, valued at approximately $665,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Quadrant Capital Group LLC raised its holdings in shares of Chemed by 184.8% in the 1st quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock worth $26,000 after purchasing an additional 61 shares in the last quarter. Bremer Bank National Association acquired a new stake in shares of Chemed during the first quarter valued at approximately $29,000. Paragon Capital Management LLC acquired a new stake in shares of Chemed during the first quarter valued at approximately $40,000. Financial Gravity Wealth Inc. acquired a new stake in shares of Chemed during the first quarter valued at approximately $49,000. Finally, Cullen Frost Bankers Inc. acquired a new stake in shares of Chemed during the first quarter valued at approximately $60,000. Institutional investors and hedge funds own 86.73% of the company’s stock.

In related news, Director George J. Walsh III sold 646 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $326.83, for a total transaction of $211,132.18. Following the transaction, the director now directly owns 7,070 shares of the company’s stock, valued at $2,310,688.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kevin J. Mcnamara sold 6,000 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $331.67, for a total transaction of $1,990,020.00. Following the transaction, the insider now directly owns 159,334 shares in the company, valued at $52,846,307.78. The disclosure for this sale can be found here. 3.96% of the stock is owned by insiders.

A number of equities research analysts have recently issued reports on the stock. Royal Bank of Canada boosted their price target on shares of Chemed to $405.00 and gave the company a “sector perform” rating in a report on Monday, July 29th. Zacks Investment Research lowered shares of Chemed from a “hold” rating to a “sell” rating in a report on Thursday, May 9th. Oppenheimer boosted their price target on shares of Chemed from $400.00 to $430.00 in a report on Thursday. Finally, ValuEngine upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, June 7th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $383.75.

Shares of CHE stock traded up $1.51 during trading hours on Friday, reaching $408.30. 87,957 shares of the stock traded hands, compared to its average volume of 106,114. Chemed Co. has a 1-year low of $260.03 and a 1-year high of $411.11. The firm has a fifty day moving average of $369.26. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.81 and a quick ratio of 0.78. The firm has a market capitalization of $6.46 billion, a price-to-earnings ratio of 34.22, a PEG ratio of 3.44 and a beta of 1.14.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, July 25th. The company reported $3.36 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.09 by $0.27. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The business had revenue of $473.60 million for the quarter, compared to analyst estimates of $471.72 million. During the same quarter in the previous year, the business earned $2.81 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. As a group, analysts forecast that Chemed Co. will post 13.03 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 3rd. Stockholders of record on Monday, August 12th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.31%. This is a positive change from Chemed’s previous quarterly dividend of $0.30. Chemed’s payout ratio is currently 10.06%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

See Also: Percentage Gainers

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.